Home Intangible Assets Ocean Tomo Releases 2025 Intangible Asset Market Value Study Results
Intangible Assets

Ocean Tomo Releases 2025 Intangible Asset Market Value Study Results

ByApril 19, 20263 Mins read253
Share


50-year study of the US market and 20 years of foreign market data informs components of market value.

NEW YORK, Feb. 12, 2026 /PRNewswire/ — Global consulting firm J.S. Held announces the release of the Ocean Tomo Intangible Asset Market Value (IAMV) study. With this release, the study now reflects a panel of 50 years of data in the US market and 20 years of data in foreign markets.

50-year study of the US market and 20 years of foreign market data informs components of market value.
50-year study of the US market and 20 years of foreign market data informs components of market value.

The study examines the components of market value, specifically the role of intangible assets, across a range of global indexes. IAMV is shown as of calendar year end by subtracting net tangible asset value from market capitalization.

Commenting on the Components of S&P 500® Market Value, economic expert and study author Matthew Johnson observes, “the composition of corporate value has undergone a fundamental transformation over the past five decades.” In 1975, tangible assets—property, plant, equipment, inventory, and other physical capital—represented 83% of the market value of companies comprising the S&P 500 index, with intangible assets accounting for only 17%. By the end of 2025, this relationship had completely inverted: intangible assets now constitute approximately 92% of S&P 500 market capitalization, while tangible assets have been reduced to a mere 8%. Johnson adds, “This 75 percentage point shift represents what Ocean Tomo has defined as ‘economic inversion’— a wholesale transformation in the nature of value creation whereby economic worth has migrated from what can be ‘touched’ to what can be ‘thought’.”

The magnitude and implications of this transformation are comparable to the Industrial Revolution of the 18th and 19th centuries. Just as the Industrial Revolution fundamentally restructured economic activity from agrarian and craft-based production to mechanized manufacturing, the intangible revolution has redefined the sources and measurement of corporate value in the 21st century. Ocean Tomo Co-founder and J.S. Held Chief Intellectual Property Officer, James E. Malackowski observes, “While the Industrial Revolution required a century to unfold fully, the intangible revolution has occurred within a single human lifespan, with particularly rapid acceleration occurring in the 1985-2005 period when intangible asset market value increased from 32% to 79%—a remarkable 47 percentage point surge in just two decades.”

The 2020-2025 period deserves special attention: S&P 500 IAMV remained stable at approximately 90% despite the Federal Reserve implementing the most aggressive monetary tightening cycle in four decades. Dr. Nikki Tavasoli, PhD, shares, “Traditional financial theory predicts that intangible-intensive firms should be highly sensitive to interest rate changes due to their long-duration cash flows and limited collateral value.” She adds, “The observed stability challenges this prediction and requires explanation, which we address in a forthcoming paper.”



Source link

Share
Previous post IESBA to examine ethical impact of private equity in accounting practices

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles
Intangible Assets

Cyberlux Corporation (OTC: CYBL) Releases Third Quarter 2023 Financial and Operational Results; Announces Transformative Actions to Refocus the Company on the Defense Technology Sector

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Cyberlux Corporation (OTC: CYBL), a leading provider of...

ByAugust 26, 2026
Intangible Assets

IPSOS | Globenewswire

Ipsos: Significant activity rebound in the second quarter Significant activity rebound in...

ByAugust 26, 2026
Intangible Assets

bsx-20251231

bsx-2025123100008857252025FYfalseP5YP7YP2YP5YP1YP1Yhttp://fasb.org/us-gaap/2025#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2025#AccountsPayableCurrenthttp://fasb.org/us-gaap/2025#AccountsPayableCurrenthttp://fasb.org/us-gaap/2025#DebtCurrenthttp://fasb.org/us-gaap/2025#LongTermDebtAndCapitalLeaseObligationshttp://fasb.org/us-gaap/2025#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2025#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2025#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2025#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrentP3YP4YP10YP5Y413iso4217:USDiso4217:USDxbrli:sharesxbrli:sharesxbrli:pureiso4217:EURutr:Ratebsx:installmentbsx:segment00008857252025-01-012025-12-310000885725us-gaap:CommonStockMember2025-01-012025-12-310000885725bsx:SeniorNotedue2027Member2025-01-012025-12-3100008857252025-06-3000008857252026-01-3000008857252024-01-012024-12-3100008857252023-01-012023-12-3100008857252025-12-3100008857252024-12-310000885725us-gaap:PreferredStockMember2024-12-310000885725us-gaap:PreferredStockMember2023-12-310000885725us-gaap:PreferredStockMember2022-12-310000885725us-gaap:PreferredStockMember2025-01-012025-12-310000885725us-gaap:PreferredStockMember2024-01-012024-12-310000885725us-gaap:PreferredStockMember2023-01-012023-12-310000885725us-gaap:PreferredStockMember2025-12-310000885725us-gaap:CommonStockMember2024-12-310000885725us-gaap:CommonStockMember2023-12-310000885725us-gaap:CommonStockMember2022-12-310000885725us-gaap:CommonStockMember2025-01-012025-12-310000885725us-gaap:CommonStockMember2024-01-012024-12-310000885725us-gaap:CommonStockMember2023-01-012023-12-3100008857252023-12-310000885725us-gaap:CommonStockMember2025-12-310000885725us-gaap:TreasuryStockCommonMember2024-12-310000885725us-gaap:TreasuryStockCommonMember2023-12-310000885725us-gaap:TreasuryStockCommonMember2022-12-310000885725us-gaap:TreasuryStockCommonMember2025-01-012025-12-310000885725us-gaap:TreasuryStockCommonMember2024-01-012024-12-310000885725us-gaap:TreasuryStockCommonMember2023-01-012023-12-310000885725us-gaap:TreasuryStockCommonMember2025-12-310000885725us-gaap:AdditionalPaidInCapitalMember2024-12-310000885725us-gaap:AdditionalPaidInCapitalMember2023-12-310000885725us-gaap:AdditionalPaidInCapitalMember2022-12-310000885725us-gaap:AdditionalPaidInCapitalMember2025-01-012025-12-310000885725us-gaap:AdditionalPaidInCapitalMember2024-01-012024-12-310000885725us-gaap:AdditionalPaidInCapitalMember2023-01-012023-12-310000885725us-gaap:AdditionalPaidInCapitalMember2025-12-310000885725us-gaap:RetainedEarningsMember2024-12-310000885725us-gaap:RetainedEarningsMember2023-12-310000885725us-gaap:RetainedEarningsMember2022-12-310000885725us-gaap:RetainedEarningsMember2025-01-012025-12-310000885725us-gaap:RetainedEarningsMember2024-01-012024-12-310000885725us-gaap:RetainedEarningsMember2023-01-012023-12-310000885725us-gaap:RetainedEarningsMember2025-12-310000885725us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310000885725us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000885725us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000885725us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-12-310000885725us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-12-310000885725us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-12-310000885725us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310000885725us-gaap:ParentMember2025-12-310000885725us-gaap:ParentMember2024-12-310000885725us-gaap:ParentMember2023-12-310000885725us-gaap:NoncontrollingInterestMember2024-12-310000885725us-gaap:NoncontrollingInterestMember2023-12-310000885725us-gaap:NoncontrollingInterestMember2022-12-310000885725us-gaap:NoncontrollingInterestMember2025-01-012025-12-310000885725us-gaap:NoncontrollingInterestMember2024-01-012024-12-310000885725us-gaap:NoncontrollingInterestMember2023-01-012023-12-310000885725us-gaap:NoncontrollingInterestMember2025-12-3100008857252022-12-310000885725us-gaap:BuildingMember2025-12-310000885725srt:MinimumMemberus-gaap:EquipmentMember2025-12-310000885725srt:MaximumMemberus-gaap:EquipmentMember2025-12-310000885725us-gaap:FurnitureAndFixturesMember2025-12-310000885725srt:MinimumMemberbsx:PatentsAndLicensesMember2025-12-310000885725srt:MaximumMemberbsx:PatentsAndLicensesMember2025-12-310000885725srt:MinimumMemberbsx:TechnologyRelatedAndCustomerRelationshipsMember2025-12-310000885725srt:MaximumMemberbsx:TechnologyRelatedAndCustomerRelationshipsMember2025-12-310000885725srt:MinimumMemberus-gaap:SoftwareDevelopmentMember2025-12-310000885725srt:MaximumMemberus-gaap:SoftwareDevelopmentMember2025-12-310000885725bsx:NaluMedicalMemberus-gaap:SubsequentEventMember2026-01-270000885725bsx:NaluMedicalMemberus-gaap:SubsequentEventMember2026-01-270000885725bsx:NaluMedicalMemberus-gaap:SubsequentEventMember2026-01-272026-01-270000885725bsx:PenumbraInc.Memberus-gaap:SubsequentEventMember2026-01-150000885725bsx:PenumbraInc.Memberus-gaap:SubsequentEventMember2026-01-152026-01-150000885725bsx:AnreiMedicalMember2025-07-110000885725bsx:AnreiMedicalMember2025-07-112025-07-110000885725bsx:SoniVieLtdMember2025-05-070000885725bsx:SoniVieLtdMember2025-05-072025-05-070000885725bsx:SoniVieLtdMember2025-05-070000885725bsx:SoniVieLtdMember2025-04-012025-06-300000885725bsx:InteraOncologyMember2025-05-060000885725bsx:InteraOncologyMember2025-05-062025-05-060000885725bsx:BoltMedicalInc.Member2025-04-010000885725bsx:BoltMedicalInc.Member2025-04-012025-04-010000885725bsx:BoltMedicalInc.Member2025-04-010000885725bsx:BoltMedicalInc.Member2025-04-012025-06-300000885725bsx:CortexInc.Member2025-01-240000885725bsx:CortexInc.Member2025-01-242025-01-240000885725bsx:Other2025AcquisitionsMember2025-01-012025-12-310000885725bsx:AllOtherMember2025-01-012025-12-310000885725bsx:AllOtherMember2025-12-310000885725bsx:BoltMedicalInc.Memberus-gaap:TechnologyBasedIntangibleAssetsMember2025-04-010000885725bsx:BoltMedicalInc.Memberus-gaap:TechnologyBasedIntangibleAssetsMember2025-04-012025-04-010000885725us-gaap:InProcessResearchAndDevelopmentMemberbsx:BoltMedicalInc.Member2025-04-010000885725us-gaap:InProcessResearchAndDevelopmentMemberbsx:SoniVieLtdMember2025-05-070000885725bsx:AllOtherMemberus-gaap:TechnologyBasedIntangibleAssetsMember2025-12-310000885725bsx:AllOtherMemberus-gaap:TechnologyBasedIntangibleAssetsMember2025-01-012025-12-310000885725bsx:AllOtherMemberus-gaap:CustomerRelationshipsMember2025-12-310000885725bsx:AllOtherMemberus-gaap:CustomerRelationshipsMember2025-01-012025-12-310000885725bsx:SilkRoadMedicalInc.Member2024-09-170000885725bsx:SilkRoadMedicalInc.Member2024-09-172024-09-170000885725bsx:AxonicsMember2024-11-150000885725bsx:AxonicsMember2024-11-152024-11-150000885725bsx:SilkRoadMedicalInc.Memberus-gaap:TechnologyBasedIntangibleAssetsMember2024-09-170000885725bsx:SilkRoadMedicalInc.Memberus-gaap:TechnologyBasedIntangibleAssetsMember2024-09-172024-09-170000885725bsx:SilkRoadMedicalInc.Memberus-gaap:CustomerRelationshipsMember2024-09-170000885725bsx:SilkRoadMedicalInc.Memberus-gaap:CustomerRelationshipsMember2024-09-172024-09-170000885725bsx:AxonicsMemberus-gaap:TechnologyBasedIntangibleAssetsMember2024-11-150000885725bsx:AxonicsMemberus-gaap:TechnologyBasedIntangibleAssetsMember2024-11-152024-11-150000885725bsx:AxonicsMemberus-gaap:CustomerRelationshipsMember2024-11-150000885725bsx:AxonicsMemberus-gaap:CustomerRelationshipsMember2024-11-152024-11-150000885725srt:MaximumMember2025-12-310000885725bsx:RevenueBasedPaymentsAndCommercializationMilestonesMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2025-12-310000885725bsx:RevenueBasedPaymentsAndCommercializationMilestonesMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MinimumMemberus-gaap:MeasurementInputDiscountRateMember2025-12-310000885725bsx:RevenueBasedPaymentsAndCommercializationMilestonesMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMemberus-gaap:MeasurementInputDiscountRateMember2025-12-310000885725bsx:RevenueBasedPaymentsAndCommercializationMilestonesMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:WeightedAverageMemberus-gaap:MeasurementInputDiscountRateMember2025-12-310000885725bsx:RevenueBasedPaymentsAndCommercializationMilestonesMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MinimumMemberbsx:MeasurementInputProbabilityOfPaymentsMember2025-12-310000885725bsx:RevenueBasedPaymentsAndCommercializationMilestonesMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMemberbsx:MeasurementInputProbabilityOfPaymentsMember2025-12-310000885725bsx:RevenueBasedPaymentsAndCommercializationMilestonesMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:WeightedAverageMemberbsx:MeasurementInputProbabilityOfPaymentsMember2025-12-310000885725bsx:ClinicalBasedRegulatoryAndOtherMilestonesMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2025-12-310000885725bsx:ClinicalBasedRegulatoryAndOtherMilestonesMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MinimumMemberus-gaap:MeasurementInputDiscountRateMember2025-12-310000885725bsx:ClinicalBasedRegulatoryAndOtherMilestonesMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMemberus-gaap:MeasurementInputDiscountRateMember2025-12-310000885725bsx:ClinicalBasedRegulatoryAndOtherMilestonesMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:WeightedAverageMemberus-gaap:MeasurementInputDiscountRateMember2025-12-310000885725bsx:ClinicalBasedRegulatoryAndOtherMilestonesMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MinimumMemberbsx:MeasurementInputProbabilityOfPaymentsMember2025-12-310000885725bsx:ClinicalBasedRegulatoryAndOtherMilestonesMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMemberbsx:MeasurementInputProbabilityOfPaymentsMember2025-12-310000885725bsx:ClinicalBasedRegulatoryAndOtherMilestonesMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:WeightedAverageMemberbsx:MeasurementInputProbabilityOfPaymentsMember2025-12-310000885725us-gaap:TechnologyBasedIntangibleAssetsMember2025-12-310000885725us-gaap:TechnologyBasedIntangibleAssetsMember2024-12-310000885725us-gaap:PatentsMember2025-12-310000885725us-gaap:PatentsMember2024-12-310000885725us-gaap:OtherIntangibleAssetsMember2025-12-310000885725us-gaap:OtherIntangibleAssetsMember2024-12-310000885725us-gaap:InProcessResearchAndDevelopmentMember2025-12-310000885725us-gaap:InProcessResearchAndDevelopmentMember2024-12-310000885725bsx:MedsurgMember2023-12-310000885725bsx:CardiovascularMember2023-12-310000885725bsx:MedsurgMember2024-01-012024-12-310000885725bsx:CardiovascularMember2024-01-012024-12-310000885725bsx:MedsurgMember2024-12-310000885725bsx:CardiovascularMember2024-12-310000885725bsx:MedsurgMember2025-01-012025-12-310000885725bsx:CardiovascularMember2025-01-012025-12-310000885725bsx:MedsurgMember2025-12-310000885725bsx:CardiovascularMember2025-12-310000885725bsx:November2019AggregateOfferingMember2024-12-310000885725bsx:November2019AggregateOfferingMember2025-12-310000885725bsx:December2027NotesMember2025-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2024-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2025-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2024-12-310000885725bsx:ForeignCurrencyDenominatedInDebtMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2025-12-310000885725bsx:ForeignCurrencyDenominatedInDebtMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2024-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2025-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-01-012025-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2025-01-012025-12-310000885725us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMembersrt:MinimumMember2025-01-012025-12-310000885725us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMembersrt:MaximumMember2025-01-012025-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2025-01-012025-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:InterestExpenseMember2025-01-012025-12-310000885725bsx:ForeignCurrencyDenominatedInDebtMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:InterestExpenseMember2025-01-012025-12-310000885725us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2025-01-012025-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2024-01-012024-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:InterestExpenseMember2024-01-012024-12-310000885725bsx:ForeignCurrencyDenominatedInDebtMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:InterestExpenseMember2024-01-012024-12-310000885725us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2024-01-012024-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2023-01-012023-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:InterestExpenseMember2023-01-012023-12-310000885725bsx:ForeignCurrencyDenominatedInDebtMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:InterestExpenseMember2023-01-012023-12-310000885725us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestExpenseMember2023-01-012023-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2025-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2025-12-310000885725us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:NondesignatedMember2025-01-012025-12-310000885725us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:NondesignatedMember2024-01-012024-12-310000885725us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:NondesignatedMember2023-01-012023-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-12-310000885725us-gaap:DesignatedAsHedgingInstrumentMember2025-12-310000885725us-gaap:DesignatedAsHedgingInstrumentMember2024-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NondesignatedMember2025-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NondesignatedMember2024-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-12-310000885725us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-12-310000885725us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:NondesignatedMember2025-12-310000885725us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:NondesignatedMember2024-12-310000885725us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-12-310000885725us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-12-310000885725us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-12-310000885725us-gaap:FairValueMeasurementsRecurringMember2025-12-310000885725us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2024-12-310000885725us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-12-310000885725us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2024-12-310000885725us-gaap:FairValueMeasurementsRecurringMember2024-12-310000885725bsx:March2026NotesMember2025-12-310000885725bsx:March2026NotesMember2024-12-310000885725bsx:December2027NotesMember2024-12-310000885725bsx:March2028SeniorNotesMember2025-12-310000885725bsx:March2028SeniorNotesMember2024-12-310000885725bsx:March2028NotesMember2025-12-310000885725bsx:March2028NotesMember2024-12-310000885725bsx:March2029NotesMember2025-12-310000885725bsx:March2029NotesMember2024-12-310000885725bsx:March2029EuroSeniorNotesMember2025-12-310000885725bsx:March2029EuroSeniorNotesMember2024-12-310000885725bsx:June2030NotesMember2025-12-310000885725bsx:June2030NotesMember2024-12-310000885725bsx:March2031NotesMember2025-12-310000885725bsx:March2031NotesMember2024-12-310000885725bsx:March2031Notes2Member2025-12-310000885725bsx:March2031Notes2Member2024-12-310000885725bsx:March2032EuroSeniorNotesMember2025-12-310000885725bsx:March2032EuroSeniorNotesMember2024-12-310000885725bsx:March2034NotesMember2025-12-310000885725bsx:March2034NotesMember2024-12-310000885725bsx:March2034Notes2Member2025-12-310000885725bsx:March2034Notes2Member2024-12-310000885725bsx:November2035NotesMember2025-12-310000885725bsx:November2035NotesMember2024-12-310000885725bsx:March2039NotesMember2025-12-310000885725bsx:March2039NotesMember2024-12-310000885725bsx:January2040NotesMember2025-12-310000885725bsx:January2040NotesMember2024-12-310000885725bsx:March2049NotesMember2025-12-310000885725bsx:March2049NotesMember2024-12-310000885725us-gaap:SeniorNotesMember2025-12-310000885725us-gaap:SeniorNotesMember2024-12-310000885725us-gaap:CapitalLeaseObligationsMember2025-12-310000885725us-gaap:CapitalLeaseObligationsMember2024-12-310000885725us-gaap:RevolvingCreditFacilityMember2021-05-100000885725bsx:RequirementAsOfDecember312025AndThroughRemainingTermOfFacilityMember2025-12-310000885725bsx:ActualCovenantMember2025-12-310000885725bsx:RequirementAsOfMarch312021Member2025-12-310000885725bsx:RequirementFourQuartersFollowingMaterialAcquisitionMember2025-12-310000885725bsx:RequirementfifthquarterfollowingqualifiedacquisitionMember2025-12-310000885725bsx:RequirementSixthQuarterFollowingQualifiedAcquisitionMember2025-12-310000885725bsx:RequirementSeventhQuarterFollowingQualifiedAcquisitionMember2025-12-310000885725bsx:RequirementEighthQuarterAndThereafterFollowingQualifiedAcquisitionMember2025-12-310000885725us-gaap:CommercialPaperMember2024-12-310000885725us-gaap:CommercialPaperMember2025-12-310000885725us-gaap:CommercialPaperMember2025-01-012025-12-310000885725us-gaap:CommercialPaperMember2024-01-012024-12-310000885725bsx:A2025EurobondOfferingSNsMember2025-02-280000885725bsx:March2031Notes2Member2025-02-210000885725bsx:March2034Notes2Member2025-02-210000885725bsx:A2025EurobondOfferingSNsMember2025-02-012025-02-280000885725bsx:March2025NotesMember2025-02-210000885725bsx:June2025NotesMember2025-06-300000885725bsx:TheOfferingAggregatePrincipalAmountMember2024-02-220000885725bsx:March2029EuroSeniorNotesMember2024-02-220000885725bsx:March2032EuroSeniorNotesMember2024-02-220000885725bsx:March2024NotesMember2024-02-220000885725bsx:EuroDenominatedFactoringArrangementsMember2025-12-310000885725bsx:EuroDenominatedFactoringArrangementsMember2025-01-012025-12-310000885725bsx:EuroDenominatedFactoringArrangementsMember2024-12-310000885725bsx:EuroDenominatedFactoringArrangementsMember2024-01-012024-12-310000885725bsx:YenDenominatedFactoringArrangementsMember2025-12-310000885725bsx:YenDenominatedFactoringArrangementsMember2025-01-012025-12-310000885725bsx:YenDenominatedFactoringArrangementsMember2024-12-310000885725bsx:YenDenominatedFactoringArrangementsMember2024-01-012024-12-310000885725bsx:RenminbiDenominatedFactoringArrangementsMember2025-12-310000885725bsx:RenminbiDenominatedFactoringArrangementsMember2025-01-012025-12-310000885725bsx:RenminbiDenominatedFactoringArrangementsMember2024-12-310000885725bsx:RenminbiDenominatedFactoringArrangementsMember2024-01-012024-12-310000885725srt:MinimumMember2025-12-310000885725srt:MaximumMember2025-01-012025-12-310000885725country:CR2025-01-012025-12-310000885725country:IE2025-01-012025-12-310000885725us-gaap:ForeignTaxJurisdictionOtherMember2025-01-012025-12-310000885725country:US2025-01-012025-12-310000885725us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2025-12-310000885725us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2024-12-310000885725bsx:DeferredTaxAssetsMember2025-12-310000885725bsx:DeferredTaxAssetsMember2024-12-310000885725bsx:DeferredTaxLiabilitiesMember2025-12-310000885725bsx:DeferredTaxLiabilitiesMember2024-12-3100008857252023-01-312023-01-3100008857252024-06-050000885725bsx:A550MCPSSeriesAMember2020-05-270000885725bsx:A550MCPSSeriesAMember2020-05-272020-05-270000885725srt:MinimumMemberbsx:A550MCPSSeriesAMember2024-01-012024-12-3100008857252023-06-012023-06-010000885725bsx:A550MCPSSeriesAMember2023-01-012023-12-3100008857252020-12-140000885725bsx:A2011LtipPlanMember2020-10-010000885725srt:MinimumMemberbsx:NonQualifiedOptionsMember2025-01-012025-12-310000885725srt:MaximumMemberbsx:NonQualifiedOptionsMember2025-01-012025-12-310000885725bsx:NonQualifiedOptionsMember2025-01-012025-12-310000885725us-gaap:EmployeeStockOptionMember2025-01-012025-12-310000885725us-gaap:CostOfSalesMember2025-01-012025-12-310000885725us-gaap:CostOfSalesMember2024-01-012024-12-310000885725us-gaap:CostOfSalesMember2023-01-012023-12-310000885725us-gaap:SellingGeneralAndAdministrativeExpensesMember2025-01-012025-12-310000885725us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-012024-12-310000885725us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-12-310000885725us-gaap:ResearchAndDevelopmentExpenseMember2025-01-012025-12-310000885725us-gaap:ResearchAndDevelopmentExpenseMember2024-01-012024-12-310000885725us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-12-310000885725us-gaap:EmployeeStockOptionMember2024-01-012024-12-310000885725us-gaap:EmployeeStockOptionMember2023-01-012023-12-310000885725srt:MinimumMemberus-gaap:EmployeeStockOptionMember2025-01-012025-12-310000885725srt:MaximumMemberus-gaap:EmployeeStockOptionMember2025-01-012025-12-310000885725srt:MinimumMemberus-gaap:EmployeeStockOptionMember2024-01-012024-12-310000885725srt:MaximumMemberus-gaap:EmployeeStockOptionMember2024-01-012024-12-310000885725srt:MinimumMemberus-gaap:EmployeeStockOptionMember2023-01-012023-12-310000885725srt:MaximumMemberus-gaap:EmployeeStockOptionMember2023-01-012023-12-310000885725srt:MinimumMember2025-01-012025-12-310000885725bsx:A2025AwardsMember2025-12-310000885725bsx:A2024AwardsMember2025-12-310000885725bsx:A2023AwardsMember2025-12-310000885725bsx:A2025AwardsMember2025-01-012025-12-310000885725bsx:A2024AwardsMember2025-01-012025-12-310000885725bsx:A2023AwardsMember2025-01-012025-12-310000885725bsx:A2025ONSGMember2025-01-012025-12-310000885725bsx:A2024ONSGMember2025-01-012025-12-310000885725bsx:A2023ONSGMember2025-01-012025-12-310000885725bsx:A2025ONSGMember2025-12-310000885725bsx:A2024ONSGMember2025-12-310000885725bsx:A2023ONSGMember2025-12-310000885725srt:MinimumMember2024-01-012024-12-310000885725srt:MaximumMember2024-01-012024-12-310000885725srt:MinimumMember2023-01-012023-12-310000885725srt:MaximumMember2023-01-012023-12-310000885725us-gaap:EmployeeStockOptionMember2025-01-012025-12-310000885725us-gaap:EmployeeStockOptionMember2024-01-012024-12-310000885725us-gaap:EmployeeStockOptionMember2023-01-012023-12-310000885725bsx:A550MCPSSeriesAMember2025-01-012025-12-310000885725bsx:A550MCPSSeriesAMember2024-01-012024-12-310000885725bsx:A550MCPSSeriesAMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:MedsurgMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:CardiovascularMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMember2025-01-012025-12-310000885725us-gaap:CorporateNonSegmentMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:MedsurgMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:CardiovascularMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMember2024-01-012024-12-310000885725us-gaap:CorporateNonSegmentMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:MedsurgMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:CardiovascularMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMember2023-01-012023-12-310000885725us-gaap:CorporateNonSegmentMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:MedsurgMember2025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:MedsurgMember2024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:CardiovascularMember2025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:CardiovascularMember2024-12-310000885725us-gaap:OperatingSegmentsMember2025-12-310000885725us-gaap:OperatingSegmentsMember2024-12-310000885725us-gaap:CorporateNonSegmentMember2025-12-310000885725us-gaap:CorporateNonSegmentMember2024-12-310000885725country:US2025-12-310000885725country:US2024-12-310000885725country:IE2025-12-310000885725country:IE2024-12-310000885725country:CR2025-12-310000885725country:CR2024-12-310000885725bsx:OtherCountriesMember2025-12-310000885725bsx:OtherCountriesMember2024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalEndoscopyEndoReportingUnitMembercountry:US2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalEndoscopyEndoReportingUnitMemberus-gaap:NonUsMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalEndoscopyEndoReportingUnitMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalEndoscopyEndoReportingUnitMembercountry:US2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalEndoscopyEndoReportingUnitMemberus-gaap:NonUsMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalEndoscopyEndoReportingUnitMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalEndoscopyEndoReportingUnitMembercountry:US2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalEndoscopyEndoReportingUnitMemberus-gaap:NonUsMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalEndoscopyEndoReportingUnitMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalUrologyandPelvicHealthReportingUnitMembercountry:US2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalUrologyandPelvicHealthReportingUnitMemberus-gaap:NonUsMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalUrologyandPelvicHealthReportingUnitMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalUrologyandPelvicHealthReportingUnitMembercountry:US2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalUrologyandPelvicHealthReportingUnitMemberus-gaap:NonUsMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalUrologyandPelvicHealthReportingUnitMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalUrologyandPelvicHealthReportingUnitMembercountry:US2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalUrologyandPelvicHealthReportingUnitMemberus-gaap:NonUsMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalUrologyandPelvicHealthReportingUnitMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalNeuromodulationNmReportingUnitMembercountry:US2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalNeuromodulationNmReportingUnitMemberus-gaap:NonUsMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalNeuromodulationNmReportingUnitMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalNeuromodulationNmReportingUnitMembercountry:US2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalNeuromodulationNmReportingUnitMemberus-gaap:NonUsMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalNeuromodulationNmReportingUnitMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalNeuromodulationNmReportingUnitMembercountry:US2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalNeuromodulationNmReportingUnitMemberus-gaap:NonUsMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:GlobalNeuromodulationNmReportingUnitMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMembercountry:USbsx:MedsurgMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberbsx:MedsurgMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMembercountry:USbsx:MedsurgMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberbsx:MedsurgMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMembercountry:USbsx:MedsurgMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberbsx:MedsurgMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:InterventionalCardiologyVascularTherapiesMembercountry:US2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:InterventionalCardiologyVascularTherapiesMemberus-gaap:NonUsMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:InterventionalCardiologyVascularTherapiesMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:InterventionalCardiologyVascularTherapiesMembercountry:US2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:InterventionalCardiologyVascularTherapiesMemberus-gaap:NonUsMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:InterventionalCardiologyVascularTherapiesMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:InterventionalCardiologyVascularTherapiesMembercountry:US2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:InterventionalCardiologyVascularTherapiesMemberus-gaap:NonUsMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:InterventionalCardiologyVascularTherapiesMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:WatchmanMembercountry:US2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:WatchmanMemberus-gaap:NonUsMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:WatchmanMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:WatchmanMembercountry:US2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:WatchmanMemberus-gaap:NonUsMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:WatchmanMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:WatchmanMembercountry:US2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:WatchmanMemberus-gaap:NonUsMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:WatchmanMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:ElectrophysiologyEPMembercountry:US2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:ElectrophysiologyEPMemberus-gaap:NonUsMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:ElectrophysiologyEPMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:ElectrophysiologyEPMembercountry:US2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:ElectrophysiologyEPMemberus-gaap:NonUsMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:ElectrophysiologyEPMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:ElectrophysiologyEPMembercountry:US2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:ElectrophysiologyEPMemberus-gaap:NonUsMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:ElectrophysiologyEPMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:CardiacRhythmManagementMembercountry:US2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:CardiacRhythmManagementMemberus-gaap:NonUsMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:CardiacRhythmManagementMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:CardiacRhythmManagementMembercountry:US2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:CardiacRhythmManagementMemberus-gaap:NonUsMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:CardiacRhythmManagementMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:CardiacRhythmManagementMembercountry:US2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:CardiacRhythmManagementMemberus-gaap:NonUsMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:CardiacRhythmManagementMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:InterventionalOncologyEmbolizationMembercountry:US2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:InterventionalOncologyEmbolizationMemberus-gaap:NonUsMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:InterventionalOncologyEmbolizationMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberbsx:InterventionalOncologyEmbolizationMembercountry:US2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:InterventionalOncologyEmbolizationMemberus-gaap:NonUsMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:InterventionalOncologyEmbolizationMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberbsx:InterventionalOncologyEmbolizationMembercountry:US2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:InterventionalOncologyEmbolizationMemberus-gaap:NonUsMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberbsx:InterventionalOncologyEmbolizationMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMembercountry:USbsx:CardiovascularMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberbsx:CardiovascularMember2025-01-012025-12-310000885725us-gaap:OperatingSegmentsMembercountry:USbsx:CardiovascularMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberbsx:CardiovascularMember2024-01-012024-12-310000885725us-gaap:OperatingSegmentsMembercountry:USbsx:CardiovascularMember2023-01-012023-12-310000885725us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberbsx:CardiovascularMember2023-01-012023-12-310000885725country:US2025-01-012025-12-310000885725us-gaap:NonUsMember2025-01-012025-12-310000885725country:US2024-01-012024-12-310000885725us-gaap:NonUsMember2024-01-012024-12-310000885725country:US2023-01-012023-12-310000885725us-gaap:NonUsMember2023-01-012023-12-310000885725us-gaap:EMEAMember2025-01-012025-12-310000885725us-gaap:EMEAMember2024-01-012024-12-310000885725us-gaap:EMEAMember2023-01-012023-12-310000885725srt:AsiaPacificMember2025-01-012025-12-310000885725srt:AsiaPacificMember2024-01-012024-12-310000885725srt:AsiaPacificMember2023-01-012023-12-310000885725bsx:LatinAmericaandCanadaMember2025-01-012025-12-310000885725bsx:LatinAmericaandCanadaMember2024-01-012024-12-310000885725bsx:LatinAmericaandCanadaMember2023-01-012023-12-310000885725bsx:EmergingMarketsMember2025-01-012025-12-310000885725bsx:EmergingMarketsMember2024-01-012024-12-310000885725bsx:EmergingMarketsMember2023-01-012023-12-310000885725us-gaap:AccumulatedTranslationAdjustmentMember2024-12-310000885725us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-12-310000885725us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-12-310000885725us-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-12-310000885725us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-01-012025-12-310000885725us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-01-012025-12-310000885725us-gaap:AccumulatedTranslationAdjustmentMember2025-12-310000885725us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-12-310000885725us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-12-310000885725us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310000885725us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-310000885725us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310000885725us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-12-310000885725us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-01-012024-12-310000885725us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-12-310000885725bsx:ExecutiveRetirementPlanMember2025-12-310000885725bsx:InternationalRetirementPlansMember2025-12-310000885725bsx:ExecutiveRetirementPlanMember2024-12-310000885725bsx:InternationalRetirementPlansMember2024-12-310000885725us-gaap:DomesticPlanMember2025-12-310000885725bsx:OtherInternationalPlansMember2025-12-310000885725us-gaap:DomesticPlanMember2024-12-310000885725bsx:OtherInternationalPlansMember2024-12-3100008857252025-10-012025-12-310000885725bsx:MiriamOSullivanMember2025-10-012025-12-310000885725bsx:MiriamOSullivanMember2025-12-31UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 10-K☑ ANNUAL REPORT PURSUANT TO SECTION...

ByAugust 26, 2026
Intangible Assets

CLO Virtual Fashion Resolves Major US Patent Infringement Case, Secures Settlement Against Style3D – Macau Business

CLO Virtual Fashion Resolves Major US Patent Infringement Case, Secures Settlement Against...

ByAugust 25, 2026
© Copyright 2026 Asset News 4U. All rights reserved.